Whalegun
Home

Benjamin Hohl, CFO: Enliven Therapeutics ELVN Sell · Filed 24/07/01

Trade details

Type
Insider sale
Amount
$41,321.4
Shares · price
1,830 sh · $22.58 a share
Held after
1,140 sh
Stock
Enliven Therapeutics ELVN
Person
Benjamin HohlCFO
Trade date
24/06/27
Filed
24/07/01
Days to filing
4 days

Sold 61.6% of holdings

Share of holding sold
61.6%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/28~24/07/27

Benjamin Hohl's recent trades

  • Benjamin Hohl

    Planned sale10b5-1 planEnliven Therapeutics

    $591.2K

    Filed 09/17

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $149.2K

    Filed 06/22

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $59K

    Filed 06/22

  • Benjamin Hohl

    Sell10b5-1 planEnliven Therapeutics

    $55.4K

    Filed 06/22

  • Benjamin Hohl

    Planned sale10b5-1 planEnliven Therapeutics

    $768.2K

    Filed 06/17

Benjamin Hohl, CFO — sold $41.3K of Enliven Therapeutics ELVN · 61.6% of holdings · 10b5-1 plan | Whalegun